Price
Financials
Consolidated, Rs crore| Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.06 | 0.06 | 0.04 | 0.03 | 0.04 | 0.02 | 0.04 | 0.04 |
| Expenses | 0.33 | 0.15 | 0.11 | 0.18 | 0.27 | 0.11 | 0.07 | 0.07 |
| Operating Profit | -0.27 | -0.09 | -0.07 | -0.15 | -0.23 | -0.09 | -0.03 | -0.03 |
| OPM % | -450.00% | -150.00% | -175.00% | -500.00% | -575.00% | -450.00% | -75.00% | -75.00% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | -0.28 | -0.10 | -0.08 | -0.16 | -0.25 | -0.10 | -0.04 | -0.04 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.28 | -0.10 | -0.08 | -0.15 | -0.24 | -0.10 | -0.03 | -0.04 |
| EPS in Rs | -0.12 | -0.04 | -0.04 | -0.07 | -0.11 | -0.04 | -0.01 | -0.02 |
| Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|
| Sales | 0.15 | 0.17 | 0.14 |
| Expenses | 0.49 | 0.71 | 0.52 |
| Operating Profit | -0.34 | -0.54 | -0.38 |
| OPM % | -226.67% | -317.65% | -271.43% |
| Other Income | 0.00 | 0.00 | 0.00 |
| Interest | 0.04 | 0.01 | 0.01 |
| Depreciation | 0.03 | 0.03 | 0.04 |
| Profit before tax | -0.41 | -0.58 | -0.43 |
| Tax % | 0.00% | 0.00% | |
| Net Profit | -0.41 | -0.58 | -0.41 |
| EPS in Rs | -0.18 | -0.26 | -0.18 |
| Dividend Payout % | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | -26% | ||
| Compounded Profit Growth | % | % | % | 33% | ||
| Stock Price CAGR | -23% | % | % | % | ||
| Return on Equity | % | % | % | -19% |
| Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|
| Equity Capital | 22.59 | 22.59 | 22.59 |
| Reserves | -19.24 | -19.81 | -19.94 |
| Borrowings | 11.54 | 12.03 | 12.04 |
| Other Liabilities | 2.29 | 2.43 | 2.49 |
| Total Liabilities | 17.18 | 17.24 | 17.18 |
| Fixed Assets | 0.10 | 0.08 | 0.06 |
| CWIP | 12.82 | 12.82 | 12.82 |
| Investments | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.26 | 4.34 | 4.30 |
| Total Assets | 17.18 | 17.24 | 17.18 |
| Mar 2022 | Mar 2023 | |
|---|---|---|
| Cash from Operating Activity | -0.28 | -0.36 |
| Cash from Investing Activity | 0.00 | 0.00 |
| Cash from Financing Activity | 0.26 | 0.38 |
| Net Cash Flow | -0.02 | 0.02 |
| Free Cash Flow | -0.28 | -0.37 |
| CFO/OP | 82% | 67% |
| Mar 2022 | Mar 2023 | |
|---|---|---|
| Debtor Days | 9,319.67 | 7,965.59 |
| Inventory Days | 86.90 | 99.55 |
| Days Payable | 451.90 | 1,161.36 |
| Cash Conversion Cycle | 8,954.67 | 6,903.77 |
| Working Capital Days | -2,628.00 | -2,512.06 |
| ROCE % | -3.84% |
| Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 26.07% | 26.07% | 26.07% | 26.07% | 26.07% | 26.07% | 26.07% | 26.07% | 26.07% | 26.07% | 26.07% | 26.07% |
| Public | 73.93% | 73.93% | 73.93% | 73.93% | 73.93% | 73.93% | 73.92% | 73.92% | 73.92% | 73.93% | 73.92% | 73.92% |
| No. of Shareholders | 12,579 | 12,572 | 12,564 | 12,558 | 12,553 | 12,548 | 12,539 | 12,534 | 12,533 | 12,530 | 12,530 | 12,523 |
Fundamentals
Market Cap₹ 3.95 Cr.
Current Price₹ 1.75
Book Value₹ 1.17
ROCE-3.84 %
ROE-18.9 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-26%
Compounded Profit Growth (TTM)33%
Consolidated figures.
Ownership
Promoter holding26.07% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | CELESTIAL | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -10.3% | -2.8% | -7.5 pts |
| 1 month | -32.7% | -6.8% | -25.9 pts |
| 3 months | -45.3% | -7.6% | -37.7 pts |
| 6 months | -43.5% | +0.4% | -44.0 pts |
| 1 year | -68.5% | -9.9% | -58.5 pts |
| 2 years | -90.0% | -13.6% | -76.5 pts |
| 3 years | -93.0% | +14.2% | -107.2 pts |
| 5 years | -97.3% | +27.9% | -125.2 pts |
Red flags
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Dec 2023Sales ₹0 Cr +33.3% vs Dec 2022.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Anthem Biosciences Ltd | 48,996 | 82.6 | 30.4 % |
| Advanced Enzyme Technologies Ltd | 3,152 | 20.0 | 14.0 % |
| CCME Global Ltd | 208 | -2.92 % | |
| Vivo Bio Tech Ltd | 36 | 7.74 % | |
| Shree Ganesh Biotech India Ltd | 19 | 1.31 % | |
| Genomic Valley Biotech Ltd | 9 | 886 | 1.02 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2024-05-17 | Annual General Meeting | |
| 2022-09-27 | Annual General Meeting | |
| 2022-06-17 | Annual General Meeting | |
| 2018-09-25 | Annual General Meeting | |
| 2017-09-22 | Annual General Meeting | |
| 2016-12-26 | Annual General Meeting | |
| 2015-11-23 | Annual General Meeting | |
| 2014-11-11 | Annual General Meeting | |
| 2013-09-13 | Annual General Meeting | |
| 2012-09-21 | Annual General Meeting | |
| 2011-09-20 | Annual General Meeting | |
| 2010-09-23 | Annual General Meeting | |
| 2009-09-23 | Agm/Div-Re.0.50 Per Share | |
| 2008-08-07 | Agm/Dividend - 10% |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Celestial Biolabs Ltd?
Celestial Biolabs Ltd (CELESTIAL) has a market capitalisation of Rs 3.95 Cr. at the 2020-03-11 close.
What were Celestial Biolabs Ltd's latest quarterly results?
In the Dec 2023 quarter, Celestial Biolabs Ltd sales was Rs 0 Cr (+33.3% vs Dec 2022) with a net loss of Rs 0 Cr.